CES1P1 (Gene)

Entrez:51716

Description:carboxylesterase 1 pseudogene 1

This gene is a member of the carboxylesterase (CES) gene family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene does not encode a protein and the sequence is similar to the CES1 gene, so represents a pseudogene of the CES1 gene. [provided by RefSeq, Jun 2010]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CES1P1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CES1P1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CES1P1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CES1P1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CES1P1.

Results found

Linked to

	Label	Description
	GSE146358 dopamine 5 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207499 sphingosine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182710 Drp1 TFAM overexpression 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155987 LMTK2 knockdown CFBE41o- 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE214306 CCM1 knockout 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE146358 dopamine 5 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE207499 sphingosine 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182710 Drp1 TFAM overexpression 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 7 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE155987 LMTK2 knockdown CFBE41o- 0 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE214306 CCM1 knockout 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.